BCR-ABL-IN-6 (9h) is an imatinib derivative and a selective inhibitor of Bcr-Abl kinase, showing activity on Bcr-AblWT (IC50: 4.6 nM) and Bcr-AblT3151 (IC50: 277 nM). BCR-ABL-IN-6 (9h) is utilized in studying chronic myeloid leukemia treatment.
Molecular Weight:
505.49
CAS Number:
[2499499-26-0]
Formula:
C27H22F3N5O2
Target:
Others|||Bcr-Abl
T63450
* VAT and and shipping costs not included. Errors and price changes excepted
